BLDR compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name

BLDRBuilders FirstSource, Inc.

Mkt capRevenueRevenue

AZNAstrazeneca PLC

Mkt capRevenueRevenue

Compare

BLDRBuilders FirstSource, Inc.

AZNAstrazeneca PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AZN: latest quarter not drawable.Method ›

Price

rebased to 0%

BLDR, solidAZN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BLDR 0

None

Shared 0

No disclosed counterparties: BLDR.

Only AZN 20

ARQTArcutis Biotherapeuticscustomer

GRALGrailsupplier

RCUSArcus Biosciencescustomer

NKTRNektar Therapeuticssupplier

16 more · AZN chain ›

Role chip = supplier or customerSource: SEC EDGAR

BLDRBuilders FirstSource, Inc.

64.54▲+2.34%· post 64.80

Mkt cap$7.0BRevenue$3.9BQ3 FY26Revenue$15.2BFY25

AZNAstrazeneca PLC

186.63▲+7.01%· post 186.35

ClosedOct 30 '26

Mkt cap$289.5BRevenue—Revenue—

Compare

ClosedOct 30 '26

BLDRBuilders FirstSource, Inc.

AZNAstrazeneca PLC

64.54▲+2.34%post 64.80

Price

186.63▲+7.01%post 186.35

$7.0B

Mkt cap

$289.5B

Q3 FY26$3.9B

Revenue

—

FY25$15.2B

Revenue

—

BLDR64.54▲+2.34%vsAZN186.63▲+7.01%ClosedOct 30 '26